Phathom falls 22% in in after-hours trading on FDA formal request for vonoprazan data Posted on February 9, 2023 By Charlielikes Stock Market
Phathom Pharma sinks 25% after FDA won’t act on vonoprazan NDA for erosive esophagitis Posted on January 3, 2023 By Charlielikes Stock Market